Results 171 to 180 of about 67,352 (288)

Second Primary Subglottic Laryngeal Carcinoma After Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone (CHOP) Chemotherapy for Non-Hodgkin Lymphoma. [PDF]

Cureus
Sanal C, Jaiswal I, Biswal P, Kharbuli L.   +3 more
europepmc   +1 more source

Development of a Machine Learning‐Based Predictive Model for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Central lymph nodes metastasis (CLNM) is common in papillary thyroid. Microcarcinoma (PTMC). Whilst prophylactic central lymph node dissection (CLND) can prevent further CLNM, it remains controversial. An accurate model to predict CLNM is therefore necessary for patients with PTMC.
Tao Li, Thomas O. Butler, Yaopeng Hu, Sha Li   +3 more
wiley   +1 more source

Papillary Thyroid Carcinoma Originating in a Male With Thyroglossal Duct Cyst: Case Presentation and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Papillary carcinoma arising in a thyroglossal duct cyst is rare and often indistinguishable from benign disease. We report a male patient with progressive cyst changes leading to diagnosis and successful Sistrunk‐based management, highlighting the need for close, appropriate imaging and individualized treatment in midline neck masses.
Nasim Abukaresh, Hossam Salameh, Tala Dweik, Anan Dawadi, Haya Taha, Sohaib Salahat, Ahmed Aljodi   +6 more
wiley   +1 more source

Influence of cognitive behavioral therapy-based psychological interventions on psychological well-being and quality of life among laryngeal carcinoma patients. [PDF]

World J Psychiatry
Tao HZ, Deng YM, Xia SF, Feng Y.
europepmc   +1 more source

Clinical Significance of Biomarkers in Oropharyngeal Squamous Cell Carcinoma: Recurrence Prediction and Treatment Response

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence largely driven by human papillomavirus (HPV) infection. Despite advances in multimodal treatment, disease recurrence remains common and limits long‐term survival, highlighting the need for reliable ...
Yunxia Chen, Wenyu Zhang, Xiang Gao, Kongling Xing, Yijing Ren, Jinyu Hu, Zhihao Xie, Ping Zhou   +7 more
wiley   +1 more source

The Impact of the Affordable Care Act on Laryngeal Carcinoma Outcomes: A NCDB Study. [PDF]

Otolaryngol Head Neck Surg
Nurimba MC, Thompson ZE, Chambers TN, Swanson MS.   +3 more
europepmc   +1 more source

MYBPC1 is a key regulator for laryngeal carcinoma formation. [PDF]

Anticancer Drugs, 2023
Liu J, Song J, Li C.
europepmc   +1 more source

What Is Your Diagnosis? Submandibular Mass in a Dog

Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler, Barbara E. Powers, Devorah M. Stowe, Nancy B. Collicutt   +3 more
wiley   +1 more source

A Multidisciplinary Approach for a Patient With Synchronous Lip and Thyroid Cancer Involving Radiotherapy

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Synchronous cancers, defined as malignancies diagnosed concurrently or within 2 months of each other, are rare, with an incidence of 1%–6%. Environmental factors such as tobacco smoking play a significant role in their development. Patients with head and neck squamous cell carcinoma (SCC) are at increased risk of second malignancies,
Aleksandra Nasiek, Paweł Polanowski, Marek Hamm, Anna Kozub, Barbara Lipka, Agnieszka Kotecka‐Blicharz, Krzysztof Składowski   +6 more
wiley   +1 more source

The impact of a patient decision aid for patients with advanced laryngeal carcinoma - a multicenter study. [PDF]

BMC Med Inform Decis Mak
Heirman AN, Petersen JF, Al-Mamgani A, Eerenstein SEJ, de Kleijn BJ, Hoebers F, Tijink BM, van der Molen L, Halmos GB, Dirven R, Stuiver MM, van den Brekel MWM.   +11 more
europepmc   +1 more source